生物标志物 生物标志物
Daniel Figdore1, Susan Ashrafzadeh-Kian1, Joshua A Bornhorst1
1Mayo Clinic, Rochester, MN, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
两种新的ApoE4蛋白质型免疫测试显示,它们可以作为评估阿尔茨海默病风险的APOE基因型定型的更快,更容易获得的替代方案. 这些测试准确地确定了ApoE4的致死性,这对于考虑使用粉样蛋白降低治疗的患者至关重要.
科学领域:
- 生物化学 生物化学
- 遗传学 是一个遗传学.
- 神经科学是一个神经科学.
背景情况:
- Apolipoprotein E (APOE) 基因,特别是 ε4 基因,是阿尔茨海默病 (AD) 的重要危险因素.
- 同胞性APOE ε4/ε4基因型增加了粉样蛋白降低疗法期间不良事件的风险.
- 目前,APOE基因型鉴定是确定ApoE4紫外质的标准,但蛋白型检测具有潜在的优势.
研究的目的:
- 为了比较两个自动化的ApoE4蛋白型免疫试验与传统的APOE基因型定型的性能.
- 评估这些新型试验的准确性和效率,以评估ApoE4的紫外质.
主要方法:
- 通过使用贝克曼·考尔特APOE ε4 RUO测定和Fujirebio Lumipulse G ApoE4和Pan-ApoE RUO测定,分析了65个EDTA血样本.
- 测试结果与基于APOE PCR的基因定型数据进行了比较.
- 用制造商提供的切割点将样品分为没有E4,异性E4和同性E4类别.
主要成果:
- 贝克曼·考尔特试验在65个样本中实现了100%的准确性,对65个样本的ApoE4复合性进行了分类.
- 在Lumipulse G测试中,在分类ApoE4紫性时,显示了94%的准确性.
- APOE基因型分布包括 ε3ε4 (46%), ε3ε3 (28%) 和 ε4ε4 (18%).
结论:
- ApoE4蛋白型免疫试验提供了一种简化且可能更容易获得的方法来评估ApoE4的结合性.
- 这些测试可以作为对接受粉样蛋白降低治疗评估的个体的基因定型的有价值的替代方案.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
746
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
746
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
511
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
511